|

IN
THE NEWS | CALENDAR

by EMILY GURNON
DR. KIM ERVIN [
see photo below right] was among
the many gynecologists on the North Coast and nationwide who
were thrown for a loop when the widespread use of hormone therapy
was called into question last summer.
The "fateful day"
was July 9, and Ervin had not watched the news that morning.
She had missed the report that a major national study was halted
because it found slightly increased risks of heart disease, breast
cancer and strokes for women taking the combined estrogen-progestin
therapy.
By the time she got to the office,
"The phones were already ringing," she said. "People
were asking: `What about this study, the Women's Health Initiative?'
And I'm like, `What study? I don't know what you're talking about.'
It was awful."
But after reading about the
study and carefully examining its methods, Ervin and other North
Coast physicians concluded that the results may not be as dire
as they initially sounded. They -- unlike some of their colleagues
-- continue to prescribe the therapy to a portion of their menopausal
patients.
"We found out it wasn't
as great a study as we thought," said Dr. Shashi Ajmani,
another Eureka gynecologist. "If you look at the data, it's
really not statistically significant for the most part."
Specifically, the heart disease and breast cancer results "border
on statistically significant or are not statistically significant,"
she said.
A less-than-earthshaking study
For decades, doctors have prescribed
estrogen, or a combination of estrogen and progestin, to patients
who are in the "perimenopausal" period, the years leading
up to the menopause, as well as those in and beyond menopause.
Nationally, about 38 percent of postmenopausal women were using
the therapy as of 1995. Estrogen has been credited with relieving
the often-brutal symptoms of menopause, which include the well-known
hot flashes and night sweats. Other less "public" symptoms
include vaginal dryness that can make for painful sex; loss of
libido; memory lapses; incontinence; cataract formation; and
mood swings.
The abrupt halting in July of
the government-funded Women's Health Initiative study, which
involved 16,000 women nationwide, came as a shock to millions
of patients and their doctors. Researchers concluded that not
only did the combined estrogen-progestin therapy not provide
one of the benefits that the medical establishment assumed it
would -- a protection against heart disease -- but the regimen
actually increased a woman's chances of developing heart disease,
breast cancer, blood clots and strokes. The benefits, slightly
less colon cancer and osteoporosis, were outweighed by the risks,
researchers decided.
But the numbers are small. In
comparison with the women who took only a placebo, the study
showed an increase of seven women per 10,000 developing heart
disease each year with hormone therapy; eight women per 10,000
developing breast cancer; and eight women per 10,000 suffering
a stroke.
The therapy also showed positive
effects: Six fewer women per 10,000 developed colon cancer; five
fewer developed osteoporosis.
(Taking estrogen alone puts
women at risk of developing cancer of the uterus, a risk which
disappears when progestin is added. Another arm of the Women's
Health Initiative study, examining women with hysterectomies
who were taking estrogen only, is continuing.)
Ervin is among those who believe
that the results of the study were "overblown." There
were flaws in the research, she said: Many of the women subjects
were older -- age 63, on average -- when they started the hormones
than is typical. "We usually start right at the menopause,"
Ervin said.
In addition, there were women
in the study who were obese, who smoked, who already had high
blood pressure. The heart disease that showed up in some of the
subjects may already have been present, though undetected, she
said.
Ajmani agreed. Other animal
studies "all point to [the conclusion that] hormones may
still be beneficial as far as preventing heart disease that doesn't
already exist," she said. "The Women's Health Initiative
did not tell us yes or no on that. It just didn't even address
it."
Not everyone is as critical.
Dr. Kathleen Harner, a Fortuna gynecologist, said the study didn't
answer all of the questions doctors have about hormone therapy.
But she said it provides some solid information.
"Because of the Women's
Health Initiative study, I don't prescribe it for what I used
to prescribe it for, which was the long-term positive health
benefits that I thought women were getting from estrogen,"
she said.
For her patients who have been
on the therapy for five years or more, "I generally encourage
them to think about either cutting back or going off. Some women
just don't want to, and that's fine, as long as they understand
there are some risks involved."
As many as half of their patients
have gone off the drugs since the study's results were made public,
local gynecologists say. Nationally, sales figures from Wyeth,
the drug company that makes Prempro (the hormone combination
given to women in the study), show a drop in the number of women
taking the hormones from 2.7 million to 1.5 million.
Agonizing about Prempro
Anne, a 54-year-old Eureka woman
who asked that her last name not be used, was one of those who
decided, initially, to stop her therapy. She first read the news
about the hormone study when she picked up a copy of a national
magazine on a trip to New York this past summer. It scared her.
"I started thinking, I
don't think I like this," she said. Anne abruptly quit her
medication, Prempro. She was past menopause, she reasoned. The
bad effects would be gone.
They weren't.
"I had a really bad time.
I stayed off them five, six weeks," she said.
"The hot flashes came back,
the night sweats came back -- it was terrible."
After a long consultation with
her doctor, Ervin, Anne decided to go back on the drugs.
Many others agonized about their
decision. Ervin said her own mother was a prime example.
Now in her 70s, her mother has
been taking Prempro "forever," Ervin said. When the
news about the study came out, her mother called her that night.
Ervin's sister Carrie -- who is not a gynecologist -- had called
their mother and told her to get off the therapy right away.
"I said, `Mom, wait, you
trust me, don't you? Then wait.' So I read through the stuff,
I did my (Internet) searches, I called her a couple days later
and said, `Stay on it.'"
A few days later, her mother
called Ervin again, saying that sister Carrie still thought she
should go off the hormones.
"If I'm having this much
trouble convincing my mother, I can't imagine what all these
other women are going through," Ervin said. "Seriously!
Even if they decided to stay on it, their friends are all saying,
(gasp!) `You're still taking that stuff?!'"
The media's presentation of
the results -- a week before they came out in the Journal
of the American Medical Association -- created a nightmare
for physicians.
"The way the data got presented
to the public was so blown out of proportion," Ervin said.
"You almost felt as if the public had this perception that
we were all trying to kill them. And it was pretty sad because
for a good number of women, hormone therapy has improved the
quality of their lives."
A lot of women simply quit their
medications cold turkey, doctors said.
"Women heard what they
did on the news and thought, `Oh my gosh, we're going to be dying
left and right from heart disease and that's why they stopped
the study earlier,'" Ajmani said. "But it really wasn't
that dramatic. I think a lot of people still don't realize that
and a lot of primary care physicians don't realize that. They're
basically going off what they saw in the media."
Different approaches
Whatever their views on the
quality of the study and the significance of its results, physicians
said they have begun to take a different approach to hormone
therapy.
Ervin said many of her patients
decided on their own to stop the therapy.
Others were immediately told
by their family physicians to discontinue it -- a reaction Ervin
called "unfortunate."
For those who still have questions,
Ervin said she explains what the study really says. Then they
discuss the patient's medical history, family history and how
she's experienced menopause.
"If they're older -- 60s,
70s -- we are encouraging them to try and decrease their dose
but not necessarily go off the therapy," she said.
One of Ervin's Eureka patients
decided to make no changes in her drug regimen.
Leslie Selvage, 57, [photo at left] said
she went on hormone therapy after initially ruling it out.
"I had made up my mind
many years ago that when I went through the change I was going
to do nothing. I was going to be tough like my mother was,"
said Selvage, a Eureka grandmother.
"But then it seemed foolish.
This was something that could help me." She'd been suffering
from night sweats and was worried about osteoporosis, after taking
a bone density test.
The new research gave her pause,
she said. But after talking at length with her doctor, she decided
the hormones were working for her. "I didn't allow it to
really panic me. My thing is tomorrow there's probably going
to be another study," with different results, she said.
Going off the drugs made Anne,
the 54-year-old Eurekan, remember how much she needed them. Her
symptoms, she said, were "horrible."
"You could be sitting in
a meeting talking to people and all of a sudden you just break
out, it looks as if you've been jogging for three hours, the
sweat just pours off of your face, you turn beet red. It was
embarrassing."
The night sweats would leave
her soaking wet, and the resulting lack of sleep made her irritable,
Anne said. "It never skipped a night. And I was seven, eight
times a day having hot flashes. It was pretty brutal." With
hormone therapy, all that went away, she said.
Another Eureka woman, age 57,
reported that she feels better sexually on hormone therapy. Without
it, she felt like a "shriveled up old prune," she said.
A tinge of uncertainty
The bottom line, Ervin and other
doctors said, is that hormones continue to be very effective
for alleviating menopausal symptoms.
"That is still the primary
indication for hormone replacement: a woman who just feels lousy,"
Ajmani said. "She's having hot flashes, night sweats, poor
sleep, memory's just shot, really moody, depressed mood. Some
women just feel better on it. There's a sense of well-being that
you can't really describe that a lot of women talk about. All
of those things are still reasons to have women on hormones."
But the discussion is different
today, she said.
"It's not, `Oh, it helps
everybody, it's good for everything, go ahead and take it.' Now
it's like, `OK, here's the data, we still don't know about the
heart disease, maybe there's an increased risk, maybe not, because
honestly, the Women's Health Initiative does not address that.
"We just don't know from
that study. Somebody else is gonna have to start over."
The Alternative way
MANY WOMEN WHO ARE UNCOMFORTABLE
taking the combined estrogen-progestin therapy, or who have been
advised by their doctors to stop, have tried other methods that
may relieve menopausal symptoms.
Dr. Peggy Grossman, a family
physician in Eureka, said she recommends an estrogen compound
that is derived not from pregnant mares -- as are many prescription
estrogen products -- but from plants. These manufactured estrogens
are "bioidentical" to those in the human body and are
assumed to have fewer side effects than animal estrogens, although
there have been no large studies to verify that. The compound
is available, with a prescription, at local pharmacies such as
Lima's or the Henderson Center Pharmacy.
Other women try natural remedies
for the following:
Heart disease. A woman's risk
of heart disease increases after menopause. Talk to your provider
about assessing your cholesterol and blood pressure. Don't smoke,
eat a healthy diet, maintain a healthy weight, get enough exercise
and reduce stress.
Osteoporosis. After menopause,
a woman is also more likely to develop osteoporosis, which can
lead to bone fractures. Talk to your provider about determining
the strength of your bones. Those not at risk can benefit from
adequate calcium and vitamin D, as well as proper exercise.
Those at risk should take calcium,
vitamin D and a prescription bone drug.
Hot flashes. Avoid getting too
warm by staying away from hot soups and beverages. Avoid hot-flash
triggers like alcohol and spicy foods. Reduce stress. When you
feel a hot flash approaching, breathe slowly and deeply. That
alone may diminish or eliminate the hot flash.
Some research suggests that
mild hot flashes can be relieved by eating soy foods or taking
a supplement of black cohosh, available at herb and natural food
stores. Effects, if any, may take a few weeks. Certain anti-depressants,
including Effexor, Prozac and Paxil, have been found to help
some women.
Vaginal dryness. Lubricants
and moisturizers available over the counter can help ease intercourse.
Severe cases of vaginal dryness respond only to prescription
estrogen, available in the form of vaginal creams, a vaginal
tablet, and a vaginal estrogen ring. Estrogen used in this way
is not absorbed to a significant extent into the bloodstream,
and thus is not associated with any negative side effects.
There is no scientific evidence
to support claims of the benefits of dong quai, angelica, evening
primrose, wild yams or dehydroepiandrosterone (DHEA), other commonly
used treatments for menopause symptoms.
Doctors recommend that you talk
with your gynecologist before quitting hormone therapy. Tapering
off gradually, rather than abruptly, will help your body adjust
to the change.
Sources: North American Menopause
Society, www.menopause.org and American College of Obstetricians
and Gynecologists, www.acog.org
-- by Emily Gurnon
IN
THE NEWS | CALENDAR
Comments? E-mail the Journal: ncjour@northcoast.com

© Copyright 2002, North Coast Journal,
Inc.
|